Profitelligence Profitelligence · Filing Ledger Open BSX research →

Form 8-K · Current Report · Filed 2024-11-22

Boston Scientific Approves 2025 Compensation Programs

Boston Scientific Corporation's Board of Directors approved the 2025 Annual Bonus Plan and two performance share programs on November 19, 2024.

Filer
Boston Scientific Corporation BSX · NYSE
Filed
Accession
0000885725-24-000081
CIK
0000885725
Signal
UnratedHealthcare

Details

These programs are designed to align executive compensation with company performance and shareholder interests, offering bonuses and performance shares based on the company's financial and operational achievements.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

No viable tag
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$91.50

Next session

-2.5%

Since filing

-48.9%

Latest close

$46.73

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from BSX reporting the same item, with the next session's move:

Exhibits (3)

About Boston Scientific Corporation

Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another BSX filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts